Trial Profile
Effect of Rosuvastatin on Endothelial Function in Patients With Diabetes and Glaucoma.
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Hypercholesterolaemia
- Focus Pharmacodynamics
- 20 Nov 2014 Status changed from active,no longer recruiting to withdrawn prior to enrolment as reported by ClinicalTrials.gov.
- 18 Jun 2009 New trial record